ImmuPharma (LON:IMM) Trading Down 11.6% – Here’s What Happened

by · The Cerbat Gem

Shares of ImmuPharma plc (LON:IMM – Get Free Report) were down 11.6% on Wednesday . The company traded as low as GBX 2.50 ($0.03) and last traded at GBX 2.57 ($0.03). Approximately 6,519,809 shares were traded during mid-day trading, a decline of 43% from the average daily volume of 11,538,609 shares. The stock had previously closed at GBX 2.90 ($0.04).

ImmuPharma Trading Down 8.8 %

The stock has a market capitalization of £10.27 million, a price-to-earnings ratio of -4.18 and a beta of 1.53. The company has a fifty day moving average of GBX 3.87 and a two-hundred day moving average of GBX 2.49.

ImmuPharma Company Profile

(Get Free Report)

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.

Featured Articles